Abstract
Alzheimer’s disease (AD) is a severe neurodegenerative ailment of the brain, affecting millions of elderly people globally. It has also created a great health concern in the future. Several acquired disease conditions and some other factors enhance the chance of developing AD. No treatment can completely cure AD. Scientific literature has established that vitamins have a number of targets in the aetiology of AD through which they act to prevent the neuronal dysfunction in the disease. Thus, by understanding the role of vitamins, we are able to state that vitamins can be a good choice to overcome the detrimental effects of AD. Antioxidant vitamins play a major role because they act by reducing the degree of oxidative stress in the brain. The categories of vitamins having promising effects in declining the course of AD and its symptoms are reviewed. Low vitamin intake can increase the chances of acquiring AD. Fortunately, these significant vitamins that protect the brain can be acquired through various fruits and vegetables that are discussed here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Allen RH, Stabler SP, Savage DG, Lindenbaum J (1990) Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 34(2):90–98
Allison AC (2001) The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses 57(2):151–155
Apel K, Hirt H (2004) Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 55:373–399
Bachurin SO, Gavrilova SI, Samsonova A, Barreto GE, Aliev G (2018) Mild cognitive impairment due to Alzheimer disease: contemporary approaches to diagnostics and pharmacological intervention. Pharmacol Res 129:216–226
Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M (2001) Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30(3):235–241
Breteler MM (2000) Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 21(2):153–160
Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72(2):751–756
Chan A, Shea TB (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J Alzheimer's Dis 9(4):399–405
Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71(2):621S–629S
Dayon L, Guiraud SP, Corthésy J, Da Silva L, Migliavacca E, Tautvydaitė D, Oikonomidi A, Moullet B, Henry H, Métairon S, Marquis J, Descombes P, Collino S, Martin FJ, Montoliu I, Kussmann M, Wojcik J, Bowman GL, Popp J (2017) One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond. Alzheimers Res Ther 9(1):43
Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD (2013) Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 110(23):9523–9528
Dursun E, Gezen-Ak D (2019) Vitamin D basis of Alzheimer's disease: from genetics to biomarkers. Hormones (Athens) 18(1):7–15
Ferland G (2012) Vitamin K, an emerging nutrient in brain function. Biofactors 38(2):151–157
Fessel J (2021) Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing. Alzheimer's dementia (N. Y.) 7(1):e12199
Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT (1999) Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM 92(1):39–45
Goetz CG, Pappert EJ (1999) Textbook of clinical neurology. W.B. Saunders, Philladelphia
Granic A, Hill TR, Kirkwood TB, Davies K, Collerton J, Martin-Ruiz C, von Zglinicki T, Saxby BK, Wesnes KA, Collerton D, Mathers JC, Jagger C (2015) Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ study. Eur J Neurol 22(1):106–1e7
Harrison FE (2012) A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease. J Alzheimers Dis 29(4):711–726
Hazell AS, Faim S, Wertheimer G, Silva VR, Marques CS (2013) The impact of oxidative stress in thiamine deficiency: a multifactorial targeting issue. Neurochem Int 62(5):796–802
Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349(9046):151–154
Joodi G, Ansari N, Khodagholi F (2011) Chitooligosaccharide-mediated neuroprotection is associated with modulation of Hsps expression and reduction of MAPK phosphorylation. Int J Biol Macromol 48(5):726–735
Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J (1998) Effective treatment of cobalamin deficiency with oral cobalamin. Blood 92(4):1191–1198
Liao WC, Chen JR, Wang YJ, Tseng GF (2010) Methylcobalamin, but not methylprednisolone or pleiotrophin, accelerates the recovery of rat biceps after ulnar to musculocutaneous nerve transfer. Neuroscience 171(3):934–949
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Mukadam N (2020) Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet 396(10248):413–446
Lu'o'ng KV, Nguyen LT (2011) Role of thiamine in Alzheimer's disease. Am J Alzheimers Dis Other Dement 26(8):588–598
Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G (2019) Effects of folic acid and vitamin B12, alone and in combination on cognitive function and inflammatory factors in the elderly with mild cognitive impairment: a single-blind experimental design. Curr Alzheimer Res 16(7):622–632
Malouf R, Grimley Evans J (2003) The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 4:CD004393
Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, Mecocci P (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 8(4):285–305
Maqbool MA, Aslam M, Akbar W, Iqbal Z (2018) Biological importance of vitamins for human health: a review. J Agric Basic Sci 2(3):50–58
Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827(1):65–75
Montilla-López P, Muñoz-Agueda MC, FeijóoLópez M, Muñoz-Castañeda JR, Bujalance-Arenas I, Túnez-Fiñana I (2002) Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells. Eur J Pharmacol 451(3):237–243
Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2(7):425–428
Ono K, Yamada M (2012) Vitamin a and Alzheimer's disease. Geriatr Gerontol Int 12(2):180–188
Persson T, Popescu BO, Cedazo-Minguez A (2014) Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail? Oxidative Med Cell Longev 2014:1
Polidori MC, Ruggiero C, Croce MF, Raichi T, Mangialasche F, Cecchetti R, Pelini L, Paolacci L, Ercolani S, Mecocci P (2015) Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease. J Neural transm 122(4):523–530
Popescu A, German M (2021) Vitamin K2 holds promise for Alzheimer’s prevention and treatment. Nutrients 13(7):2206
Powers HJ (2003) Riboflavin (vitamin B-2) and health. Am J Clin Nutr 77(6):1352–1360
Presse N, Shatenstein B, Kergoat MJ, Ferland G (2008) Low vitamin K intakes in community-dwelling elders at an early stage of Alzheimer's disease. J Am Diet Assoc 108(12):2095–2099
Rivière S, Birlouez-Aragon I, Nourhashémi F, Vellas B (1998) Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 13(11):749–754
Robinson N, Grabowski P, Rehman I (2018) Alzheimer's disease pathogenesis: is there a role for folate? Mech Ageing Dev 174:86–94
Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9(4):339–349
Rudzki L, Stone TW, Maes M, Misiak B, Samochowiec J, Szulc A (2021) Gut microbiota-derived vitamins–underrated powers of a multipotent ally in psychiatric health and disease. Prog Neuro-Psychopharmacol Biol Psychiatry 107:110240
Saedisomeolia A, Ashoori M (2018) Riboflavin in human health: a review of current evidences. Adv Food Nutr Res 83:57–81
Savage DG, Lindenbaum J (1995) 11 neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol 8(3):657–678
Schaffer WM, Bronnikova TV (2012) Peroxidase-ROS interactions. Nonlin Dyn 68(3):413–430
Serbinova E, Kagan V, Han D, Packer L (1991) Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med 10(5):263–275
Sodhi RK, Singh N (2014) Retinoids as potential targets for Alzheimer's disease. Pharmacol Biochem Behav 120:117–123
Swaminathan A, Jicha GA (2014) Nutrition and prevention of Alzheimer’s dementia. Front Aging Neurosci 6:282
Takasaki J, Ono K, Yoshiike Y, Hirohata M, Ikeda T, Morinaga A, Takashima A, Yamada M (2011) Vitamin a has anti-oligomerization effects on amyloid-β in vitro. Alzheimer's Dis 27(2):271–280
Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer disease, Alzheimer Dis 179–196
Vogel T, Dali-Youcef N, Kaltenbach G, Andres E (2009) Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 63(7):1061–1067
Wahlin A, Hill RD, Winblad B, Bäckman L (1996) Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: a population-based study. Psychol Aging 11(3):487–496
WHO (2015 Serum and red blood cell folate concentrations for assessing folate status in populations. https://apps.who.int/iris/handle/10665/75584
Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88(6):1785–1792
Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JC, Cache County Study Group (2004) Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County study. Arch Neurol 61(1):82–88
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kiruba, J., Justin Thenmozhi, A., Jayalakshmi, M., Arockia Jeya Yasmi Prabha, E. (2023). Role of Vitamins in Alzheimer’s Disease. In: Thenmozhi, A.J., Manivasagam, T. (eds) Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach. Nutritional Neurosciences. Springer, Singapore. https://doi.org/10.1007/978-981-99-0677-2_2
Download citation
DOI: https://doi.org/10.1007/978-981-99-0677-2_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0676-5
Online ISBN: 978-981-99-0677-2
eBook Packages: MedicineMedicine (R0)